Fox News Media
Fox News Media
Fox Business
Fox Nation
Fox News Audio
Fox Weather
Outkick
Fox Noticias
Books

U.S.
Politics
World
Opinion
Media
- Fox Nation Coverage
Entertainment
Sports
Lifestyle
Health
Video
AI
More

Expand / Collapse search

Home
WAR WITH IRAN
DHS SHUTDOWN
SAVE AMERICA ACT
NANCY GUTHRIE

Games
Deals
FOX Business
Science & Tech
Watch Live
Apps & Products

Games
Deals
FOX Business
Science & Tech
Watch Live
Apps & Products

Facebook
Twitter
Instagram
RSS
Newsletters

Terms of Use
Privacy Policy
Your Privacy Choices
Closed Caption Policy
Help
Contact Us
Accessibility Statement
News Sitemap
Video Sitemap

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by LSEG.

ADVERTISEMENT

Kayla Rivas

Kayla Rivas is a Health reporter and joined Fox News in April 2020.

ADVERTISEMENT

Fox Business Articles

J&J requests FDA emergency approval for COVID-19 booster shot

Healthcare October 5, 2021

J&J requests FDA emergency approval for COVID-19 booster shot

Johnson & Johnson requested emergency approval of its COVID-19 vaccine booster shot for individuals 18 years and older, the company announced Tuesday.

J&J to seek authorization for COVID-19 booster shot this week: report

Healthcare October 4, 2021

J&J to seek authorization for COVID-19 booster shot this week: report

Johnson & Johnson is preparing to request authorization of its COVID-19 booster vaccine early this week, the New York Times reported, citing officials familiar with the matter.

Merck to request emergency approval for COVID-19 antiviral pill

Healthcare October 1, 2021

Merck to request emergency approval for COVID-19 antiviral pill

Merck will request emergency approval for an experimental oral COVID-19 antiviral drug, molnupiravir, after a late-stage trial indicated an approximate 50% risk reduction for hospitalization or death among patients with mild to moderate COVID-19.

Pfizer-BioNTech submit COVID-19 vaccine data to FDA for kids 5-11

Healthcare September 28, 2021

Pfizer-BioNTech submit COVID-19 vaccine data to FDA for kids 5-11

Pfizer-BioNTech submitted clinical trial data from a COVID-19 vaccine study among kids ages 5-11 to the Food and Drug Administration (FDA), the companies announced Tuesday. A request for emergency approval is anticipated to follow in the coming weeks.

FDA decision on Pfizer's COVID-19 vaccine booster mixed: What to know

Healthcare September 17, 2021

FDA decision on Pfizer's COVID-19 vaccine booster mixed: What to know

An independent committee advising the FDA voted against Pfizer’s COVID-19 vaccine booster shot.

U.S.
Politics
World
Opinion
Media
- FOX Nation Coverage
Entertainment
Sports
Lifestyle
Health
Deals
FOX Business
Science & Tech
Games
Watch Live
About
Apps & Products

U.S.
Politics
World
Opinion
Media
- FOX Nation Coverage
Entertainment
Sports
Lifestyle
Health
Deals
FOX Business
Science & Tech
Games
Watch Live
About
Apps & Products

Facebook
Twitter
Instagram
Youtube
Flipboard
LinkedIn
Slack
RSS
Newsletters
Spotify
iHeartRadio

Terms of Use
Privacy Policy
Your Privacy Choices
Closed Caption Policy
Help
Contact Us
Accessibility Statement
News Sitemap
Video Sitemap

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by LSEG.